Thus, this in vitro assay indicates recovering effect of high-frequency rMS by upregulation of dopamine concentration and DR4 and BDNF gene expressions in the AD model neuronal cells, which were downregulated by Aβ42 administration. The gene discussed is TNFRSF10A; the disease is Alzheimer disease.